UBS AM’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
395,965
+38,247
| +11% | +$1.09M | ﹤0.01% | 1301 |
|
|
2025
Q1 | $10.6M | Buy |
357,718
+25,329
| +8% | +$748K | ﹤0.01% | 1199 |
|
|
2024
Q4 | $9.67M | Sell |
332,389
-16,452
| -5% | -$478K | ﹤0.01% | 1263 |
|
|
2024
Q3 | $16M | Sell |
348,841
-1,524
| -0.4% | -$70K | ﹤0.01% | 1031 |
|
|
2024
Q2 | $14.3M | Buy |
350,365
+270,067
| +336% | +$11M | ﹤0.01% | 994 |
|
|
2024
Q1 | $2.05M | Sell |
80,298
-10,867
| -12% | -$277K | ﹤0.01% | 1685 |
|
|
2023
Q4 | $825K | Hold |
91,165
| – | – | ﹤0.01% | 2127 |
|
|
2023
Q3 | $582K | Buy |
91,165
+34,859
| +62% | +$222K | ﹤0.01% | 2234 |
|
|
2023
Q2 | $864K | Hold |
56,306
| – | – | ﹤0.01% | 2067 |
|
|
2023
Q1 | $864K | Sell |
56,306
-3,871
| -6% | -$59.4K | ﹤0.01% | 2067 |
|
|
2022
Q4 | $1.34M | Buy |
60,177
+36,455
| +154% | +$809K | ﹤0.01% | 1715 |
|
|
2022
Q3 | $387K | Hold |
23,722
| – | – | ﹤0.01% | 2433 |
|
|
2022
Q2 | $345K | Hold |
23,722
| – | – | ﹤0.01% | 2430 |
|
|
2022
Q1 | $438K | Sell |
23,722
-9,556
| -29% | -$176K | ﹤0.01% | 2502 |
|
|
2021
Q4 | $791K | Buy |
33,278
+23,722
| +248% | +$564K | ﹤0.01% | 2335 |
|
|
2021
Q3 | $235K | Buy |
+9,556
| New | +$235K | ﹤0.01% | 2665 |
|